Completion of SK Pharmteco’s French Subsidiary Yposkesi 2nd Plant… Operations to Begin in 2024
Small-and-medium-sized Business/Ventu
SK Pharmteco, SK’s Contract Development Manufacturing Organization(CDMO) subsidiary completed its second plant in Europe for Cell and Gene Therapy(CGT) and will accelerate its expansion into the global market.
![LG그룹[T01] [NSPAD]LG그룹](https://file.nspna.com/ad/T01_lgfuture_5298.gif)
![삼성전자[T01] [NSPAD]삼성전자](https://file.nspna.com/ad/T01_samsung_5043.gif)